Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
114.50 USD | -0.72% | -0.86% | +5.30% |
02:04pm | Merck: positive results for HPV vaccine | CF |
01:04pm | Merck's HPV Vaccine Meets Main Goal in Phase 3 Study in Japanese Males | MT |
- Stock Market
- Equities
- MRK Stock
- News Merck & Co., Inc.
- Merck, Orion Convert Ongoing Collaboration Into Exclusive Global License for Opevesostat